Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression
Abstract
:1. Introduction
2. Materials and Methods
2.1. Media, Cells, and Viruses
2.2. Plasmids
2.3. Western Blotting
2.4. The Gaussia and Cypridia Luciferase Assays
2.5. Measurement of Plaque Sizes
2.6. Statistical Analysis
3. Results
3.1. The Gn/gLuc Precursor-1 Does Not Efficiently Generate Gn/gLuc Fusion Proteins
3.2. Precursor-2 Plays a Major Role in Gn/gLuc Expression
3.3. The Viral Untranslated Region Sequence, Upstream of the 4th or 5th AUG, Affects Efficient Generation of Gn/gLuc Fusion Proteins
3.4. The rMP-12 Encoding the AUG2-M Mutation or the rMP-12 Encoding the Δ2 + 3 Mutation Replicate Less Efficiently Than Parental rMP-12
4. Discussion
5. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
Abbreviations
RVF | Rift Valley fever |
RVFV | Rift Valley fever virus |
L-segment | Large-segment |
M-segment | Medium-segment |
S-segment | Small-segment |
DIVA | Differentiation of infected from Vaccinated animals |
gLuc | Gaussia luciferase |
cLuc | Cypridia luciferase |
PKR | dsRNA-dependent protein kinase |
IFN | Interferon |
FBS | Fetal bovine serum |
BHK | Baby hamster kidney |
MOI | Multiplicity of infection |
SDS-PAGE | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
CAG promoter | The cytomegalovirus early enhancer/chicken β actin promoter |
UTR | Untranslated region |
References
- Pepin, M.; Bouloy, M.; Bird, B.H.; Kemp, A.; Paweska, J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): An update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010, 41. [Google Scholar] [CrossRef]
- Ikegami, T. Molecular biology and genetic diversity of Rift Valley fever virus. Antivir. Res. 2012, 95, 293–310. [Google Scholar] [CrossRef] [PubMed]
- Ikegami, T.; Makino, S. The pathogenesis of Rift Valley fever. Viruses 2011, 3, 493–519. [Google Scholar] [CrossRef] [PubMed]
- Bird, B.H.; Ksiazek, T.G.; Nichol, S.T.; Maclachlan, N.J. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 2009, 234, 883–893. [Google Scholar] [CrossRef] [PubMed]
- Linthicum, K.J.; Davies, F.G.; Kairo, A.; Bailey, C.L. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J. Hyg. 1985, 95, 197–209. [Google Scholar] [CrossRef] [PubMed]
- Ikegami, T.; Makino, S. Rift valley fever vaccines. Vaccine 2009, 27, D69–D72. [Google Scholar] [CrossRef] [PubMed]
- Billecocq, A.; Spiegel, M.; Vialat, P.; Kohl, A.; Weber, F.; Bouloy, M.; Haller, O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 2004, 78, 9798–9806. [Google Scholar] [CrossRef] [PubMed]
- Bouloy, M.; Janzen, C.; Vialat, P.; Khun, H.; Pavlovic, J.; Huerre, M.; Haller, O. Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J. Virol. 2001, 75, 1371–1377. [Google Scholar] [CrossRef] [PubMed]
- Le May, N.; Dubaele, S.; Proietti de Santis, L.; Billecocq, A.; Bouloy, M.; Egly, J.M. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004, 116, 541–550. [Google Scholar] [CrossRef]
- Le May, N.; Mansuroglu, Z.; Leger, P.; Josse, T.; Blot, G.; Billecocq, A.; Flick, R.; Jacob, Y.; Bonnefoy, E.; Bouloy, M. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog. 2008, 4, e13. [Google Scholar] [CrossRef] [PubMed]
- Ikegami, T.; Narayanan, K.; Won, S.; Kamitani, W.; Peters, C.J.; Makino, S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2α phosphorylation. PLoS Pathog. 2009, 5, e1000287. [Google Scholar] [CrossRef] [PubMed]
- Kalveram, B.; Lihoradova, O.; Ikegami, T. NSs protein of Rift Valley fever virus promotes post-translational downregulation of the TFIIH subunit p62. J. Virol. 2011, 85, 6234–6243. [Google Scholar] [CrossRef] [PubMed]
- Habjan, M.; Pichlmair, A.; Elliott, R.M.; Overby, A.K.; Glatter, T.; Gstaiger, M.; Superti-Furga, G.; Unger, H.; Weber, F. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J. Virol. 2009, 83, 4365–4375. [Google Scholar] [CrossRef] [PubMed]
- Kakach, L.T.; Suzich, J.A.; Collett, M.S. Rift Valley fever virus M segment: Phlebovirus expression strategy and protein glycosylation. Virology 1989, 170, 505–510. [Google Scholar] [CrossRef]
- Suzich, J.A.; Collett, M.S. Rift Valley fever virus M segment: Cell-free transcription and translation of virus-complementary RNA. Virology 1988, 164, 478–486. [Google Scholar] [CrossRef]
- Suzich, J.A.; Kakach, L.T.; Collett, M.S. Expression strategy of a phlebovirus: Biogenesis of proteins from the Rift Valley fever virus M segment. J. Virol. 1990, 64, 1549–1555. [Google Scholar] [PubMed]
- Kozak, M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 1991, 115, 887–903. [Google Scholar] [CrossRef] [PubMed]
- Kreher, F.; Tamietti, C.; Gommet, C.; Guillemot, L.; Ermonval, M.; Failloux, A.B.; Panthier, J.J.; Bouloy, M.; Flamand, M. The Rift Valley fever accessory proteins NSm and P78/NSm-Gn are determinants of virus propagation in vertebrate and invertebrate hosts. Emerg. Microb. Infect. 2014, 3. [Google Scholar] [CrossRef] [PubMed]
- Morrill, J.C.; Carpenter, L.; Taylor, D.; Ramsburg, H.H.; Quance, J.; Peters, C.J. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 1991, 9, 35–41. [Google Scholar] [CrossRef]
- Morrill, J.C.; Jennings, G.B.; Caplen, H.; Turell, M.J.; Johnson, A.J.; Peters, C.J. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am. J. Vet. Res. 1987, 48, 1042–1047. [Google Scholar] [PubMed]
- Morrill, J.C.; Mebus, C.A.; Peters, C.J. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am. J. Vet. Res. 1997, 58, 1110–1114. [Google Scholar] [PubMed]
- Ikegami, T.; Hill, T.E.; Smith, J.K.; Zhang, L.; Juelich, T.L.; Gong, B.; Slack, O.A.; Ly, H.J.; Lokugamage, N.; Freiberg, A.N. Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and L segments. J. Virol. 2015, 89, 7262–7276. [Google Scholar] [CrossRef] [PubMed]
- Nishiyama, S.; Lokugamage, N.; Ikegami, T. The L-, M- and S-segments of Rift Valley fever virus MP-12 vaccine independently contribute to a temperature-sensitive phenotype. J. Virol. 2016, 90, 3735–3744. [Google Scholar] [CrossRef] [PubMed]
- Miller, M.M.; Bennett, K.E.; Drolet, B.S.; Lindsay, R.; Mecham, J.O.; Reeves, W.K.; Weingartl, H.M.; Wilson, W.C. Evaluation of the efficacy, potential for vector transmission, and duration of immunity of MP-12, an attenuated Rift Valley fever virus vaccine candidate, in sheep. Clin. Vaccine Immunol. 2015, 22, 930–937. [Google Scholar] [CrossRef] [PubMed]
- Won, S.; Ikegami, T.; Peters, C.J.; Makino, S. NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J. Virol. 2006, 80, 8274–8278. [Google Scholar] [CrossRef] [PubMed]
- Gerrard, S.R.; Bird, B.H.; Albarino, C.G.; Nichol, S.T. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 2007, 359, 459–465. [Google Scholar] [CrossRef] [PubMed]
- Terasaki, K.; Won, S.; Makino, S. The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts anti-apoptotic function. J. Virol. 2013, 87, 676–682. [Google Scholar] [CrossRef] [PubMed]
- Gerrard, S.R.; Nichol, S.T. Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology 2007, 357, 124–133. [Google Scholar] [CrossRef] [PubMed]
- Tannous, B.A.; Kim, D.E.; Fernandez, J.L.; Weissleder, R.; Breakefield, X.O. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 2005, 11, 435–443. [Google Scholar] [CrossRef] [PubMed]
- Gerrard, S.R.; Nichol, S.T. Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J. Virol. 2002, 76, 12200–12210. [Google Scholar] [CrossRef] [PubMed]
- Bar, S.; Rommelaere, J.; Nuesch, J.P. Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis. PLoS Pathog. 2013, 9, e1003605. [Google Scholar] [CrossRef] [PubMed]
- Ito, N.; Takayama-Ito, M.; Yamada, K.; Hosokawa, J.; Sugiyama, M.; Minamoto, N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microb. Immunol. 2003, 47, 613–617. [Google Scholar] [CrossRef]
- Ikegami, T.; Won, S.; Peters, C.J.; Makino, S. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 2006, 80, 2933–2940. [Google Scholar] [CrossRef] [PubMed]
- Kalveram, B.; Lihoradova, O.; Indran, S.V.; Ikegami, T. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J. Vis. Exp. 2011. [Google Scholar] [CrossRef] [PubMed]
- Kalveram, B.; Lihoradova, O.; Indran, S.V.; Lokugamage, N.; Head, J.A.; Ikegami, T. Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. Virology 2013, 435, 415–424. [Google Scholar] [CrossRef] [PubMed]
- Adobe Photoshop Elements, version 7.0 for Windows; Adobe Systems Incorporated: San Jose, CA, USA, 2008.
- GraphPad Prism, version 6.05 for Windows; GraphPad Software, Inc.: La Jolla, CA, USA, 2014.
- Spik, K.; Shurtleff, A.; McElroy, A.K.; Guttieri, M.C.; Hooper, J.W.; SchmalJohn, C. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 2006, 24, 4657–4666. [Google Scholar] [CrossRef] [PubMed]
- Morrill, J.C.; Mebus, C.A.; Peters, C.J. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am. J. Vet. Res. 1997, 58, 1104–1109. [Google Scholar] [PubMed]
- Morrill, J.C.; Laughlin, R.C.; Lokugamage, N.; Pugh, R.; Sbrana, E.; Weise, W.J.; Adams, L.G.; Makino, S.; Peters, C.J. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine 2013, 31, 559–565. [Google Scholar] [CrossRef] [PubMed]
- Morrill, J.C.; Laughlin, R.C.; Lokugamage, N.; Wu, J.; Pugh, R.; Kanani, P.; Adams, L.G.; Makino, S.; Peters, C.J. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine 2013, 31, 4988–4994. [Google Scholar] [CrossRef] [PubMed]
- Huiskonen, J.T.; Overby, A.K.; Weber, F.; Grunewald, K. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: Evidence for GN-GC glycoprotein heterodimers. J. Virol. 2009, 83, 3762–3769. [Google Scholar] [CrossRef] [PubMed]
- Rusu, M.; Bonneau, R.; Holbrook, M.R.; Watowich, S.J.; Birmanns, S.; Wriggers, W.; Freiberg, A.N. An assembly model of Rift Valley fever virus. Front Microb. 2012, 3. [Google Scholar] [CrossRef] [PubMed]
- Fontana, J.; Lopez-Montero, N.; Elliott, R.M.; Fernandez, J.J.; Risco, C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Genom. Comput. Sci. Virus Res. 2008, 10, 2012–2028. [Google Scholar] [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Phoenix, I.; Lokugamage, N.; Nishiyama, S.; Ikegami, T. Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. Viruses 2016, 8, 151. https://doi.org/10.3390/v8060151
Phoenix I, Lokugamage N, Nishiyama S, Ikegami T. Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. Viruses. 2016; 8(6):151. https://doi.org/10.3390/v8060151
Chicago/Turabian StylePhoenix, Inaia, Nandadeva Lokugamage, Shoko Nishiyama, and Tetsuro Ikegami. 2016. "Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression" Viruses 8, no. 6: 151. https://doi.org/10.3390/v8060151